Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include News-Medical, Stuff, 90.5 WESA and Endpoints News. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 8h ago.
Quick answers
Why is "Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addicti" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (5)
- How GLP-1 Drugs May Help Treat Addiction: Mechanisms and Clinical Evidence News-Medical · 1d ago
- The weight-loss drug dropping a ‘bomb’ on alcohol addiction Stuff · 1d ago
- Could Ozempic help treat addiction? An Allegheny County study aims to find out 90.5 WESA · 1d ago
- Big trials push beyond obesity to see if GLP-1s can quell alcohol, drug cravings Endpoints News · 1d ago
- Telehealth leapfrogs FDA approval with off-label GLP-1 prescriptions for addiction STAT · 1d ago
Topics
Related trends
Popular kids' toothpastes among 4M tubes recalled nationwide
A nationwide recall affecting millions of tubes of popular children's toothpastes has been announced by the FDA.
Startup Deploys AI-Engineered Virus on Human Patient
A human patient has received the first treatment utilizing an AI-engineered bacteriophage virus.
Roche builds blockbuster BTK case for fenebrutinib in multiple sclerosis as FDA decision approaches
Roche presents new trial data for its experimental MS pill fenebrutinib as an FDA decision approaches.
Tests of Unapproved Weight- Loss Drug Reveal Its Dangers
Recent laboratory tests and digital monitoring reveal severe health dangers linked to an unapproved experimental weight-loss drug.
What to know about GLP-1s and cannabis use
Recent coverage examines connections between GLP-1 medications and cannabis use amid nationwide recalls and heightened risk levels.
FDA Announces Nationwide Recall of More Than 4 Million Tubes of Toothpaste
The FDA has issued a nationwide recall of over 4.3 million toothpaste tubes, sparking urgent consumer alerts across the United States.